Table 1.
Characteristic | Description | |
---|---|---|
Demographic | Age (years)* | 66 (55 to 69) |
Gender (male)† | 45 | |
Height (m)‡ | 1.69 (0.10) | |
Weight (kg)‡ | 75.2 (13.6) | |
Time since diagnosis (years)* | 2.8 (0.8 to 5.4) | |
Hoehn and Yahr staging (1/2/3/4/5)† | 17/50/6/5/1 | |
Antiparkinsonian medication | Any (yes)† | 36 |
Dopaminergic agonist | 26 | |
Monoamine oxidase‐B inhibitor | 25 | |
Amantadine | 8 | |
Levodopa combination | 15 | |
Anticholinergic | 18 | |
Laxative | Any (yes)† | 10 |
Bulk | 9 | |
Osmotic | 5 | |
Other | 0 | |
β‐blocker | Propranolol† | 3 |
Antidepressant | Citalopram† | 4 |
Median (interquartile range).
Count.
Mean (SD).